GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » Short-Term Capital Lease Obligation

ASKA Pharmaceutical Holdings Co (TSE:4886) Short-Term Capital Lease Obligation : 円0 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is ASKA Pharmaceutical Holdings Co Short-Term Capital Lease Obligation?

ASKA Pharmaceutical Holdings Co's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円0 Mil.

ASKA Pharmaceutical Holdings Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for ASKA Pharmaceutical Holdings Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASKA Pharmaceutical Holdings Co Short-Term Capital Lease Obligation Chart

ASKA Pharmaceutical Holdings Co Annual Data
Trend Mar22 Mar23 Mar24
Short-Term Capital Lease Obligation
- - -

ASKA Pharmaceutical Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ASKA Pharmaceutical Holdings Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

ASKA Pharmaceutical Holdings Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of ASKA Pharmaceutical Holdings Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

ASKA Pharmaceutical Holdings Co (TSE:4886) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
TSE:2929 TSE:4577 TSE:9273 TSE:4554 TSE:4595 TSE:4538 TSE:4574 TSE:4582 TSE:4524 TSE:4512 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532
Website
https://www.aska-pharma-hd.co.jp
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.

ASKA Pharmaceutical Holdings Co (TSE:4886) Headlines

No Headlines